These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 11703319)
1. Breast cancer resistance protein expression and resistance to daunorubicin in blast cells from patients with acute myeloid leukaemia. Sargent JM; Williamson CJ; Maliepaard M; Elgie AW; Scheper RJ; Taylor CG Br J Haematol; 2001 Nov; 115(2):257-62. PubMed ID: 11703319 [TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the aurora-B kinase inhibitor barasertib-hQPA. Grundy M; Seedhouse C; Russell NH; Pallis M BMC Cancer; 2011 Jun; 11():254. PubMed ID: 21679421 [TBL] [Abstract][Full Text] [Related]
3. Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias. Benderra Z; Faussat AM; Sayada L; Perrot JY; Chaoui D; Marie JP; Legrand O Clin Cancer Res; 2004 Dec; 10(23):7896-902. PubMed ID: 15585622 [TBL] [Abstract][Full Text] [Related]
4. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells. Svirnovski AI; Shman TV; Serhiyenka TF; Savitski VP; Smolnikova VV; Fedasenka UU Hematology; 2009 Aug; 14(4):204-12. PubMed ID: 19635183 [TBL] [Abstract][Full Text] [Related]
5. Expression of breast cancer resistance protein in blast cells from patients with acute leukemia. Ross DD; Karp JE; Chen TT; Doyle LA Blood; 2000 Jul; 96(1):365-8. PubMed ID: 10891476 [TBL] [Abstract][Full Text] [Related]
6. Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia. van der Kolk DM; Vellenga E; Scheffer GL; Müller M; Bates SE; Scheper RJ; de Vries EG Blood; 2002 May; 99(10):3763-70. PubMed ID: 11986234 [TBL] [Abstract][Full Text] [Related]
7. The 4'-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells. Brooks TA; O'Loughlin KL; Minderman H; Bundy BN; Ford LA; Vredenburg MR; Bernacki RJ; Priebe W; Baer MR Invest New Drugs; 2007 Apr; 25(2):115-22. PubMed ID: 17072745 [TBL] [Abstract][Full Text] [Related]
8. Breast cancer resistance protein in drug resistance of primitive CD34+38- cells in acute myeloid leukemia. Raaijmakers MH; de Grouw EP; Heuver LH; van der Reijden BA; Jansen JH; Scheper RJ; Scheffer GL; de Witte TJ; Raymakers RA Clin Cancer Res; 2005 Mar; 11(6):2436-44. PubMed ID: 15788695 [TBL] [Abstract][Full Text] [Related]
9. Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML). van den Heuvel-Eibrink MM; Wiemer EA; Prins A; Meijerink JP; Vossebeld PJ; van der Holt B; Pieters R; Sonneveld P Leukemia; 2002 May; 16(5):833-9. PubMed ID: 11986944 [TBL] [Abstract][Full Text] [Related]
10. VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein. Minderman H; O'Loughlin KL; Pendyala L; Baer MR Clin Cancer Res; 2004 Mar; 10(5):1826-34. PubMed ID: 15014037 [TBL] [Abstract][Full Text] [Related]
11. The role of breast cancer resistance protein in acute lymphoblastic leukemia. Plasschaert SL; van der Kolk DM; de Bont ES; Kamps WA; Morisaki K; Bates SE; Scheffer GL; Scheper RJ; Vellenga E; de Vries EG Clin Cancer Res; 2003 Nov; 9(14):5171-7. PubMed ID: 14613996 [TBL] [Abstract][Full Text] [Related]
12. CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age. van den Heuvel-Eibrink MM; van der Holt B; Burnett AK; Knauf WU; Fey MF; Verhoef GE; Vellenga E; Ossenkoppele GJ; Löwenberg B; Sonneveld P Ann Hematol; 2007 May; 86(5):329-37. PubMed ID: 17340137 [TBL] [Abstract][Full Text] [Related]
13. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. Jonker JW; Smit JW; Brinkhuis RF; Maliepaard M; Beijnen JH; Schellens JH; Schinkel AH J Natl Cancer Inst; 2000 Oct; 92(20):1651-6. PubMed ID: 11036110 [TBL] [Abstract][Full Text] [Related]
14. BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia. Steinbach D; Sell W; Voigt A; Hermann J; Zintl F; Sauerbrey A Leukemia; 2002 Aug; 16(8):1443-7. PubMed ID: 12145683 [TBL] [Abstract][Full Text] [Related]
15. Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines. Scheffer GL; Maliepaard M; Pijnenborg AC; van Gastelen MA; de Jong MC; Schroeijers AB; van der Kolk DM; Allen JD; Ross DD; van der Valk P; Dalton WS; Schellens JH; Scheper RJ Cancer Res; 2000 May; 60(10):2589-93. PubMed ID: 10825126 [TBL] [Abstract][Full Text] [Related]
16. Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia. van der Pol MA; Broxterman HJ; Pater JM; Feller N; van der Maas M; Weijers GW; Scheffer GL; Allen JD; Scheper RJ; van Loevezijn A; Ossenkoppele GJ; Schuurhuis GJ Haematologica; 2003 Feb; 88(2):134-47. PubMed ID: 12604403 [TBL] [Abstract][Full Text] [Related]
17. Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2. Kowalski P; Stein U; Scheffer GL; Lage H Cancer Gene Ther; 2002 Jul; 9(7):579-86. PubMed ID: 12082458 [TBL] [Abstract][Full Text] [Related]
18. Breast cancer resistance protein (BCRP) in acute leukemia. Plasschaert SL; Van Der Kolk DM; De Bont ES; Vellenga E; Kamps WA; De Vries EG Leuk Lymphoma; 2004 Apr; 45(4):649-54. PubMed ID: 15160935 [TBL] [Abstract][Full Text] [Related]
19. MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia. Ho MM; Hogge DE; Ling V Exp Hematol; 2008 Apr; 36(4):433-42. PubMed ID: 18249061 [TBL] [Abstract][Full Text] [Related]
20. Transport of topoisomerase I inhibitors by the breast cancer resistance protein. Potential clinical implications. Schellens JH; Maliepaard M; Scheper RJ; Scheffer GL; Jonker JW; Smit JW; Beijnen JH; Schinkel AH Ann N Y Acad Sci; 2000; 922():188-94. PubMed ID: 11193894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]